Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PEPD | P12955 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3897341 | 0.78 | MAPT (0.35) | MAPTTSHR | |
| SCHEMBL1093310 | 0.77 | MAPT (0.37) | MAPTTSHRCHRM2CHRM4CHRM1 | |
| SCHEMBL27685046 | 0.77 | TSHR (0.40) | PEPDTSHR | |
| Methacrylic Acid SCHEMBL7860381 | 0.77 | TSHR (0.44) | MAPTTSHRCHRM2CHRM4CHRM1 | |
| SCHEMBL17266586 | 0.76 | MAPT (0.39) | MAPTTSHRCHRM2CHRM4CHRM1 | |
| SCHEMBL554115 | 0.75 | — | — | |
| SCHEMBL25435789 | 0.75 | MAPT (0.41) | MAPTTSHRCHRM2CHRM4CHRM1 | |
| SCHEMBL13195782 | 0.75 | — | — | |
| SCHEMBL149835 | 0.75 | — | — | |
| SCHEMBL13195784 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109536-A | Adhesive film, optical member including the same, and optical display device including the same | 三星SDI株式会社 | 2022-09-27 | — | — | CN | disclosed |
| EP-2279230-B1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH AZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2012-01-18 | — | — | EP | disclosed |
| US-7714076-B2 | Acrylic pressure-sensitive adhesives with aziridine crosslinking agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-05-11 | — | — | US | disclosed |
| US-20090246390-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH AZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090246390-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH AZIRIDINE CROSSLINKING AGENTS | AAAS, CDH1, PTK2 | MAPT 2272/4885PEPD 334/4885TSHR 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.